Menu

Nordic Gene Study Requires Consent

A company has been ordered to stop estimating Icelanders’ genotypes and linking them to hospital records.

Jun 24, 2013
Kate Yandell

FLICKR, SHAURY NASHThe company deCODE Genetics is known for harnessing Iceland’s excellent genealogical records to aid in massive studies of genetics and disease. But according to an article in the Science print edition, Iceland’s Data Protection Authority (DPA) ruled last month (May 28) that the company must seek consent before continuing genetics studies using estimated data on 280,000 Icelanders—some living and some dead—who did not agree to be studied.

Already deCODE has published 6 papers in Nature and the New England Journal of Medicine using the data-collecting strategy, which involves estimating genotypes of relatives of 120,000 volunteers who did agree to let the company study their genetics. In some cases the company is able to link the estimated genetic data to hospital records of patients who volunteered to be part of another Icelandic research study, for which they did not consent to undergo genetic testing.

Kári Stefánsson, founder and CEO of deCODE, argues that the company, which is now owned by Amgen, is not violating patient privacy because it is not actually sequencing citizens’ DNA. “These are just conjectures about people, hypotheses,” he told Science.

The Icelandic government is giving the company until November to demonstrate they have obtained consent from their subjects.

(For a free online version of the article, see ScienceInsider.)

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!